HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clean Air Plan update

This article was originally published in The Rose Sheet

Executive Summary

California Air Resources Board will postpone review of the Clean Air Plan to provide more time for public comment, CARB says in 1March 25 announcement. Public comments will be accepted until May 15, as board consideration, originally scheduled for CARB's April 25-26 meeting, will be rescheduled for a later date, agency adds. Technical workshop slated for early April also will be moved to a later date. Developed by CARB staff, Clean Air Plan aims to reduce reactive gas emissions, including those generated from voluntary organic compounds found in personal care products (2"The Rose Sheet" March 25, 2002, p. 3)...

You may also be interested in...

CARB VOC Limits In Additional Personal Care Categories Outlined In Plan

The California Air Review Board should consider evaluating additional personal care product categories for possible reductions in reactive organic gas emissions, according to a proposed comprehensive Clean Air Plan released March 15

Biocon And Mylan's Fulphila And Insulin Plans On Track

Biocon and Mylan press ahead with plans to broaden patient access in the US to biosimilar pegfilgrastim and are enthused with the initial uptake for their trastuzumab biosimilar ahead of more upcoming competition. A mid-2020 US launch for partnered insulin glargine is also on course.

Pharma Has High Hopes Of Pilot On Simultaneous Advice From EU Countries

Drug companies in the EU explain how a new pilot scheme on national-level scientific advice service can benefit drug developers. 




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts